Skip to main content
Erschienen in: Rheumatology International 5/2017

13.03.2017 | Food for Thought

Criteria sets for primary Sjogren’s syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features

verfasst von: Yasemin Kabasakal, Gul Kitapçıoğlu, Gonca Karabulut, Mehmet Tezcan, Ayse Balkarlı, Adem Aksoy, Şule Yavuz, Sema Yılmaz, Timuçin Kaşifoğlu, Umut Kalyoncu, Ediz Dalkılıç, Abdurrahman Tufan, Rıdvan Mercan, Fatih Yıldız, Taşkın Şentürk, Fatoş Önen, Cemal Bes, Eren Erken, Ercan Tunç, Sevil Kamalı, Emine Tarhan, Ayten Yazıcı, Nurşen Düzgün, Müge Bıçakçıgil, Sedat Yılmaz, Mustafa Özmen, Lale Öcal, Fatma Alibaz-Öner, Dilek Solmaz, Veli Çobankara, Selim Nalbant, Esen Kasapoğlu Günal, Derya Kaşkari, Berna Göker

Erschienen in: Rheumatology International | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Patients with primary Sjogren’s syndrome (pSS) may go undiagnosed or be misclassified due to the insidious nature and wide spectrum of the disease. The available several classification criteria emphasize glandular findings. We aimed to analyze the efficiency of various classification criteria sets in patients diagnosed on the clinical basis by expert opinion and to compare those pSS patients who fulfilled these criteria with those who did not. This is a multicenter study in which 834 patients from 22 university-based rheumatology clinics are included. Diagnosis of pSS was made on the clinical basis by the expert opinion. In this study, we only interviewed patients once and collected available data from the medical records. The European criteria, American-European Consensus Group (AECG) and American College of Rheumatology (ACR) Sjogren’s criteria were applied. Majority of the patients were women (F/M was 20/1). The median duration from the first pSS-related symptom to diagnosis was significantly shorter in men (2.5 ± 2.3 vs 4.3 ± 5.9 years) (p = 0 < 0.016). When the European, AECG and ACR Sjogren’s criteria were applied, 666 patients (79.9%) satisfied at least one of them. In total, 539 patients (64.4%) satisfied the European, 439 (52.6%) satisfied the AECG, and 359 (43%) satisfied the ACR criteria. Among the entire group, 250 patients (29.9%) satisfied all and 168 (20.1%) met none of the criteria. The rates of extraglandular organ involvements were not different between patients who met at least one of the criteria sets and those who met none. There is an urgent need for the modification of the pSS criteria sets to prevent exclusion of patients with extraglandular involvements as the dominant clinical features.
Literatur
2.
Zurück zum Zitat Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. European Study Group on Classification Criteria for Sjögren’s Syndrome. Ann Rheum Dis 61(6):554–558CrossRefPubMedPubMedCentral Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. European Study Group on Classification Criteria for Sjögren’s Syndrome. Ann Rheum Dis 61(6):554–558CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schiødt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan J, Daniels T; Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups (2012) American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 64(4):475–487CrossRef Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schiødt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan J, Daniels T; Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups (2012) American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 64(4):475–487CrossRef
4.
Zurück zum Zitat Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA (2006) Epidemiology of primary Sjögren’s syndrome in north-west Greece, 1982–2003. Rheumatology (Oxford) 45(2):187–191CrossRef Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA (2006) Epidemiology of primary Sjögren’s syndrome in north-west Greece, 1982–2003. Rheumatology (Oxford) 45(2):187–191CrossRef
5.
Zurück zum Zitat vanBijsterveld OP (1969) Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 82(1):10–14CrossRef vanBijsterveld OP (1969) Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 82(1):10–14CrossRef
6.
Zurück zum Zitat Rasmussen A, Ice JA, Li H, Grundahl K, Kelly JA, Radfar L, Stone DU, Hefner KS, Anaya JM, Rohrer M, Gopalakrishnan R, Houston GD, Lewis DM, Chodosh J, Harley JB, Hughes P, Maier-Moore JS, Montgomery CG, Rhodus NL, Farris AD, Segal BM, Jonsson R, Lessard CJ, Scofield RH, Sivils KL (2014) Comparison of the American-European Consensus Group Sjogren’s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis 73(1):31–38. doi:10.1136/annrheumdis-2013-203845 CrossRefPubMed Rasmussen A, Ice JA, Li H, Grundahl K, Kelly JA, Radfar L, Stone DU, Hefner KS, Anaya JM, Rohrer M, Gopalakrishnan R, Houston GD, Lewis DM, Chodosh J, Harley JB, Hughes P, Maier-Moore JS, Montgomery CG, Rhodus NL, Farris AD, Segal BM, Jonsson R, Lessard CJ, Scofield RH, Sivils KL (2014) Comparison of the American-European Consensus Group Sjogren’s syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis 73(1):31–38. doi:10.​1136/​annrheumdis-2013-203845 CrossRefPubMed
7.
Zurück zum Zitat Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY et al (1996) Assessment of the European classification criteria for Sjogren’s syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren’s syndrome. Ann Rheum Dis 55:116–121CrossRefPubMedPubMedCentral Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY et al (1996) Assessment of the European classification criteria for Sjogren’s syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren’s syndrome. Ann Rheum Dis 55:116–121CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Cornec D, Saraux A, Cochener B, Pers JO, Jousse-Joulin S, Renaudineau Y, Marhadour T (2014) Devauchelle-PensecVLevel of agreement between 2002 American-European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome and reasons for discrepancies. Arthritis Res Ther 16(2):R74CrossRefPubMedPubMedCentral Cornec D, Saraux A, Cochener B, Pers JO, Jousse-Joulin S, Renaudineau Y, Marhadour T (2014) Devauchelle-PensecVLevel of agreement between 2002 American-European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome and reasons for discrepancies. Arthritis Res Ther 16(2):R74CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Vitali C, Bootsma H, Bowman SJ, Dorner T, Gottenberg JE, Mariette X, Ramos-Casals M, Ravaud P, Seror R, Theander E, Tzioufas AG (2013) Classification criteria for Sjogren’s syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis 72(4):476–478CrossRefPubMed Vitali C, Bootsma H, Bowman SJ, Dorner T, Gottenberg JE, Mariette X, Ramos-Casals M, Ravaud P, Seror R, Theander E, Tzioufas AG (2013) Classification criteria for Sjogren’s syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis 72(4):476–478CrossRefPubMed
10.
Zurück zum Zitat Brun JG, Madland TM, Gjesdal CB, Bertelsen LT (2002) Sjögren’s syndrome in an out-patient clinic: classification of patients according to the preliminary European criteria and the proposed modified European criteria. Rheumatology (Oxford) 41(3):301–304CrossRef Brun JG, Madland TM, Gjesdal CB, Bertelsen LT (2002) Sjögren’s syndrome in an out-patient clinic: classification of patients according to the preliminary European criteria and the proposed modified European criteria. Rheumatology (Oxford) 41(3):301–304CrossRef
11.
Zurück zum Zitat Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, BencivelliW, Bernstein RM et al (1993) Preliminary criteria for the classification of Sjögren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36(3):340–347CrossRefPubMed Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, BencivelliW, Bernstein RM et al (1993) Preliminary criteria for the classification of Sjögren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36(3):340–347CrossRefPubMed
12.
Zurück zum Zitat Malladi AS, Sack KE, Shiboski SC, Shiboski CH, Baer AN, Banushree R, Dong Y, Helin P, Kirkham BW, Li M, Sugai S, Umehara H, Vivino FB, Vollenweider CF, Zhang W, Zhao Y, Greenspan JS, Daniels TE, Criswell LA (2012) Primary Sjögren’s syndrome as a systemic disease: a study of participants enrolled in an international Sjögren’s syndrome registry. Arthritis Care Res (Hoboken) 64(6):911–918CrossRef Malladi AS, Sack KE, Shiboski SC, Shiboski CH, Baer AN, Banushree R, Dong Y, Helin P, Kirkham BW, Li M, Sugai S, Umehara H, Vivino FB, Vollenweider CF, Zhang W, Zhao Y, Greenspan JS, Daniels TE, Criswell LA (2012) Primary Sjögren’s syndrome as a systemic disease: a study of participants enrolled in an international Sjögren’s syndrome registry. Arthritis Care Res (Hoboken) 64(6):911–918CrossRef
13.
Zurück zum Zitat Hsu CW, Su YJ, Chang WN, Tsai NW, Chiu WC, Cheng BC, Su CM, Huang CR, Chang YT, Lu CH (2014) The association between serological biomarkers and primary Sjogren’s syndrome associated with peripheral polyneuropathy. Biomed Res Int 2014:902492PubMedPubMedCentral Hsu CW, Su YJ, Chang WN, Tsai NW, Chiu WC, Cheng BC, Su CM, Huang CR, Chang YT, Lu CH (2014) The association between serological biomarkers and primary Sjogren’s syndrome associated with peripheral polyneuropathy. Biomed Res Int 2014:902492PubMedPubMedCentral
14.
Zurück zum Zitat Ryu YS, Park SH, Lee J, Kwok SK, Ju JH, Kim HY, Jeon CH (2013) Follow-up of primary Sjogren’s syndrome patients presenting positive anti-cyclic citrullinated peptides antibody. Rheumatol Int )(Issue 6):1443CrossRef Ryu YS, Park SH, Lee J, Kwok SK, Ju JH, Kim HY, Jeon CH (2013) Follow-up of primary Sjogren’s syndrome patients presenting positive anti-cyclic citrullinated peptides antibody. Rheumatol Int )(Issue 6):1443CrossRef
15.
Zurück zum Zitat Manuel Ramos-Casals, Pilar Brito-Zerón, Raphaèle Seror, Hendrika Bootsma, Simon J. Bowman, Thomas Dörner, Jacques-Eric Gottenberg, Xavier Mariette, ElkeTheander, Stefano Bombardieri, ,Salvatore De Vita, Thomas Mandl, Wan-Fai Ng, AikeKruize, AthanasiosTzioufas and Claudio Vitali on behalf of the EULAR Sjögren Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements (2015) Rheumatology (Oxford) 54(12):2230–2238 Manuel Ramos-Casals, Pilar Brito-Zerón, Raphaèle Seror, Hendrika Bootsma, Simon J. Bowman, Thomas Dörner, Jacques-Eric Gottenberg, Xavier Mariette, ElkeTheander, Stefano Bombardieri, ,Salvatore De Vita, Thomas Mandl, Wan-Fai Ng, AikeKruize, AthanasiosTzioufas and Claudio Vitali on behalf of the EULAR Sjögren Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements (2015) Rheumatology (Oxford) 54(12):2230–2238
16.
Zurück zum Zitat Palm O, Garen T, Berge Enger T, Jensen JL, Lund MB, Aaløkken TM, Gran JT (2013) Clinical pulmonary involvement in primary Sjogren’s syndrome: prevalence, quality of life and mortality–a retrospective study based on registry data. Rheumatology (Oxford) 52(1):173–179CrossRef Palm O, Garen T, Berge Enger T, Jensen JL, Lund MB, Aaløkken TM, Gran JT (2013) Clinical pulmonary involvement in primary Sjogren’s syndrome: prevalence, quality of life and mortality–a retrospective study based on registry data. Rheumatology (Oxford) 52(1):173–179CrossRef
17.
Zurück zum Zitat Brito-Zerón P, Retamozo S, Akasbi M, Gandía M, Perez-De-Lis M, Soto-Cardenas MJ, Diaz-Lagares C, Kostov B, Bove A, Bosch X, Perez-Alvarez R, Siso A (2014) Ramos-Casals M. Annular erythema in primary Sjogren’s syndrome: description of 43 non-Asian cases. Lupus 23(2):166–175CrossRefPubMed Brito-Zerón P, Retamozo S, Akasbi M, Gandía M, Perez-De-Lis M, Soto-Cardenas MJ, Diaz-Lagares C, Kostov B, Bove A, Bosch X, Perez-Alvarez R, Siso A (2014) Ramos-Casals M. Annular erythema in primary Sjogren’s syndrome: description of 43 non-Asian cases. Lupus 23(2):166–175CrossRefPubMed
18.
Zurück zum Zitat Teppo H, Revonta M (2007) A follow-up study of minimally invasive lip biopsy in the diagnosis of Sjögren’s syndrome. Clin Rheumatol 26(7):1099–1103CrossRefPubMed Teppo H, Revonta M (2007) A follow-up study of minimally invasive lip biopsy in the diagnosis of Sjögren’s syndrome. Clin Rheumatol 26(7):1099–1103CrossRefPubMed
19.
Zurück zum Zitat Plesivcnik Novljan M, Rozman B, Hocevar A, Grmek M, Kveder T, Tomsic M (2004) Incidence of primary Sjogren’s syndrome in Slovenia. Ann Rheum Dis 63:874–876CrossRefPubMed Plesivcnik Novljan M, Rozman B, Hocevar A, Grmek M, Kveder T, Tomsic M (2004) Incidence of primary Sjogren’s syndrome in Slovenia. Ann Rheum Dis 63:874–876CrossRefPubMed
20.
Zurück zum Zitat Karabulut G, Kitapcioglu G, Inal V, Kalfa M, Yargucu F, Keser G, Emmungil H, Gokmen NM, Kocanaogullari H, Aksu K (2011) Cigarette smoking in primary Sjögren’s syndrome: positive association only with ANA positivity. Mod Rheumatol 21(6):602–607CrossRefPubMed Karabulut G, Kitapcioglu G, Inal V, Kalfa M, Yargucu F, Keser G, Emmungil H, Gokmen NM, Kocanaogullari H, Aksu K (2011) Cigarette smoking in primary Sjögren’s syndrome: positive association only with ANA positivity. Mod Rheumatol 21(6):602–607CrossRefPubMed
21.
Zurück zum Zitat Goules AV, Tzioufas AG, Moutsopoulos HM (2014) Classification criteria of Sjögren’s syndrome. J Autoimmun. 48–49: 42–45CrossRefPubMed Goules AV, Tzioufas AG, Moutsopoulos HM (2014) Classification criteria of Sjögren’s syndrome. J Autoimmun. 48–49: 42–45CrossRefPubMed
22.
Zurück zum Zitat Shiboski CH, Siboski SC, Seror R, Criswell LA, Labetoulle M, Lietman A, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, the International Sjögren’s Syndrome Criteria Working Group (2017) 2016 American College of Rheumatology/European Leagues Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data driven methodology involving three international patient cohorts. Ann Rheum Dis 76:9–16CrossRefPubMed Shiboski CH, Siboski SC, Seror R, Criswell LA, Labetoulle M, Lietman A, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, the International Sjögren’s Syndrome Criteria Working Group (2017) 2016 American College of Rheumatology/European Leagues Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data driven methodology involving three international patient cohorts. Ann Rheum Dis 76:9–16CrossRefPubMed
Metadaten
Titel
Criteria sets for primary Sjogren’s syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features
verfasst von
Yasemin Kabasakal
Gul Kitapçıoğlu
Gonca Karabulut
Mehmet Tezcan
Ayse Balkarlı
Adem Aksoy
Şule Yavuz
Sema Yılmaz
Timuçin Kaşifoğlu
Umut Kalyoncu
Ediz Dalkılıç
Abdurrahman Tufan
Rıdvan Mercan
Fatih Yıldız
Taşkın Şentürk
Fatoş Önen
Cemal Bes
Eren Erken
Ercan Tunç
Sevil Kamalı
Emine Tarhan
Ayten Yazıcı
Nurşen Düzgün
Müge Bıçakçıgil
Sedat Yılmaz
Mustafa Özmen
Lale Öcal
Fatma Alibaz-Öner
Dilek Solmaz
Veli Çobankara
Selim Nalbant
Esen Kasapoğlu Günal
Derya Kaşkari
Berna Göker
Publikationsdatum
13.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 5/2017
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3691-8

Weitere Artikel der Ausgabe 5/2017

Rheumatology International 5/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Eingreifen von Umstehenden rettet vor Erstickungstod!

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.